Vice President, Global Program Leader, Orelabrutinib
About the Company
Diverse biopharmaceutical company
Industry
Biotechnology
Type
Public Company
Founded
2020
Employees
51-200
Categories
Specialties
About the Role
The Company is a global biopharmaceutical firm dedicated to the development and commercialization of immune-based therapies. They are in search of a Vice President, Global Program Leader for orelabrutinib, a role that demands a strategic and experienced professional to lead the global development of this therapy in progressive multiple sclerosis. The successful candidate will be responsible for defining and driving the integrated global program strategy, ensuring alignment with corporate objectives, and leading a high-performing cross-functional team through the Phase 3 program and future registrational activities. Key responsibilities include program vision, clinical execution, lifecycle planning, risk management, development optimization, launch preparation, and integrated execution across various functions.
Applicants for this role at the company should hold an advanced degree in life sciences, with a preference for MD, PhD, or PharmD, and have at least 15 years of experience in drug development, particularly in the fields of neurology or immunology. The role requires a proven track record in leading late-stage global programs, strong knowledge of regulatory strategy, clinical development, and commercialization planning. The ideal candidate will possess exceptional communication, leadership, and cross-functional collaboration skills, and be adept at anticipating and addressing key development and regulatory risks. The position also demands a leader who can champion the program across the organization, engage with executive leadership, and represent the program in external interactions with regulatory agencies and key opinion leaders.
Hiring Manager Title
Chief Scientific Officer
Travel Percent
Less than 10%
Functions
Vice President • Waltham, MA, United States